訊映

+0.35 (+2.36%)最後更新 2026-09-11

台灣 · 上市 · 生技醫療業

15.15349成交張數8.81本益比0.85股價淨值比1.98%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

元

負債總額 / 資產總額

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	40	25	35.5%	2.40	17.40	9.9%	6.3%	1.3	0.9
2026Q1	39	25	33.4%	2.49	17.45	4.5%	2.9%	0.6	0.0
2025Q4	38	25	33.1%	2.28	17.35	3.3%	2.2%	2.5	1.7
2025Q3	39	25	35.2%	1.79	16.83	2.8%	1.9%	0.5	-0.0
2025Q2	37	24	33.4%	1.81	16.19	-1.7%	-1.1%	-0.2	-1.4
2025Q1	38	25	33.1%	1.91	16.86	3.4%	2.4%	0.4	-1.1
2024Q4	37	25	30.5%	1.98	16.95	3.8%	2.8%	0.3	-0.5
2024Q3	34	24	28.4%	1.85	16.64	1.0%	0.7%	-0.9	-2.8
2024Q2	36	25	30.4%	1.74	16.81	2.1%	1.5%	1.6	0.9
2024Q1	31	24	22.3%	2.24	16.46	0.9%	0.7%	-0.3	-0.8
2023Q4	31	24	21.9%	2.28	16.45	0.1%	0.1%	0.4	-0.5
2023Q3	32	24	26.0%	2.01	18.42	1.4%	0.9%	0.1	0.0
2023Q2	30	22	27.6%	1.81	18.40	3.8%	2.5%	-0.0	-3.0
2023Q1	31	22	27.3%	1.86	19.47	5.7%	3.9%	-0.4	-0.8
2022Q4	31	18	39.7%	1.84	18.54	8.1%	4.9%	1.8	1.6
2022Q3	30	18	41.5%	1.74	18.46	8.5%	5.1%	0.7	-1.6
2022Q2	29	17	41.3%	2.00	17.96	6.9%	4.1%	0.4	0.1
2022Q1	27	17	37.4%	2.32	18.17	3.7%	2.4%	-0.4	-0.6
2021Q4	28	17	39.5%	2.13	17.95	2.5%	1.6%	1.5	1.4
2021Q3	28	17	38.9%	2.17	17.84	4.8%	3.0%	0.2	-0.1
2021Q2	28	17	39.7%	2.21	17.43	6.3%	3.7%	-0.5	-0.7
2021Q1	26	16	35.8%	1.66	17.28	7.8%	4.6%	-0.9	-1.2
2020Q4	25	17	31.4%	1.95	18.21	8.6%	5.5%	1.5	1.1
2020Q3	26	17	33.7%	2.29	17.81	8.9%	5.6%	0.0	0.4
2020Q2	23	13	43.2%	1.48	16.02	11.6%	6.7%	0.3	-0.0
2020Q1	23	12	45.5%	1.49	15.56	11.4%	6.9%	-0.4	-0.5
2019Q4	22	13	41.4%	1.72	16.41	9.9%	6.2%	0.1	-0.2
2019Q3	20	12	40.9%	2.05	15.46	11.2%	7.1%	0.7	0.6
2019Q2	19	11	38.7%	1.62	14.92	12.5%	7.5%	-0.8	-0.9
2019Q1	19	13	30.5%	2.60	16.98	11.7%	7.7%	0.5	0.3
2018Q4	19	12	31.5%	2.47	16.55	–	–	0.8	0.7
2018Q3	17	12	29.4%	2.90	16.03	–	–	-0.2	-0.3
2018Q2	20	12	40.3%	1.47	15.84	–	–	0.1	0.0
2018Q1	20	13	37.3%	1.78	16.88	–	–	0.7	0.5